ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) traded up 5.9% during mid-day trading on Wednesday . The stock traded as high as $1.50 and last traded at $1.44. Approximately 445,607 shares changed hands during trading, an increase of 2,092% from the average session volume of 20,327 shares. The stock had previously closed at $1.36.
ImmunoPrecise Antibodies Price Performance
The firm’s 50-day simple moving average is $1.56 and its two-hundred day simple moving average is $1.48.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd (OTCMKTS:IPATF) is a Canada-based contract research organization specializing in the discovery and development of therapeutic antibodies. The company provides a full suite of preclinical research services, from target validation and lead identification through to humanization and optimization. Its capabilities encompass hybridoma, phage display, single B cell sorting and next-generation sequencing platforms to accelerate antibody candidate selection and characterization.
ImmunoPrecise serves biopharmaceutical and biotechnology partners worldwide, offering customized solutions for projects in immuno-oncology, infectious diseases, autoimmunity and other therapeutic areas.
Read More
- Five stocks we like better than ImmunoPrecise Antibodies
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
